Wikipedia -WSS

Wikipedia

author：knowledge 2025-08-11 08:01:02 - browse：2

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Gain of function research would be limited under House proposal

WSS

Does good food count as health care? Study aims to find out

A daunting task: navigating dual Medicare, Medicaid eligibility

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

In key trial, Verve's treatment lowers cholesterol levels in patients

David Sabatini, ex

Surge of respiratory disease in China has likely explanation

explore

Wikipedia

knowledge

How to save PrEP access — and even expand it

Anthos stroke drug appears safer than common blood thinner

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Congress must reauthorize a committee to support older Americans

Moonlake's readout produced a cash windfall. Risks remain

STAT letters to the editor on burnt

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Tori Bowie and the unacceptable rates of Black maternal death

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

hotspot

Hospitals look to new technology to keep health care workers safe

World's first CRISPR

Hospitals look to new technology to keep health care workers safe

Spinal cord stimulation reduces pain in amputees, study finds

David Sabatini, ex

Supreme Court wrestles with OxyContin maker's bankruptcy deal

hotspot

entertainment

entertainment

knowledge